Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B
Series: International Review of Cell and Molecular Biology; 399;
- Publisher's listprice EUR 171.00
-
70 922 Ft (67 545 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 7 092 Ft off)
- Discounted price 63 830 Ft (60 791 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
70 922 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 1 March 2026
- ISBN 9780443414138
- Binding Hardback
- No. of pages277 pages
- Size 229x152 mm
- Weight 450 g
- Language English 700
Categories
Long description:
Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part B delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. Specific chapters in this new release include Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers, Identification of circulating biomarkers for cancer therapy-related cardiovascular toxicity, Extracellular Vesicles as Dynamic Biomarkers: Monitoring Therapeutic Responses and Drug Resistance in Cancer, and more.
This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care.
Table of Contents:
1. Preface
Sheila Spada
2. Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers
Valsamo Anagnostou, Blair Landon, Jinny Huang, Ellie Evangelopoulou and Jenna Canzoniero
3. Identification of circulating biomarkers for cancer therapy-related cardiovascular toxicity
Junjie Xiao, Junli Gao, Michail Spanos and Qiulian Zhou
4. title yet to decide
Fabio Grizzi
5. Extracellular Vesicles as Dynamic Biomarkers: Monitoring Therapeutic Responses and Drug Resistance in Cancer
Sherien M. El-Daly, Shaimaa Gouhar and Zakaria Abd Elmageed
6. Title yet to decide
Mulong Du
